A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Abramson Cancer Center at Penn Medicine
National Institutes of Health Clinical Center (CC)
Fondazione Italiana Linfomi - ETS
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Centre for Human Drug Research, Netherlands
Fox Chase Cancer Center
City of Hope Medical Center
Kymera Therapeutics, Inc.
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Eisai Inc.
BeiGene
Dartmouth-Hitchcock Medical Center
Takeda
4SC AG
University of Pittsburgh
Mundipharma Research Limited
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Columbia University
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
City of Hope Medical Center
Wake Forest University Health Sciences
Eisai Inc.
Stanford University
National Institutes of Health Clinical Center (CC)
University of Nebraska
University of Nebraska
Children's Oncology Group
Columbia University
Eastern Cooperative Oncology Group
Genmab
Stanford University
Genmab
Universitätsmedizin Mannheim
Atara Biotherapeutics
Karyopharm Therapeutics Inc
Centre for Human Drug Research, Netherlands
St. Olavs Hospital
Ludwig Institute for Cancer Research
Columbia University
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Peter MacCallum Cancer Centre, Australia
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)